← Open Payments lookup

TIFFANY DUPREE: Open Payments

NPI 1467904557 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,975 in 75 payments from 14 companies in 2025. Trend: 2023 $814 · 2024 $895 · 2025 $1,975

Food & beverage: $1,876Education: $100
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.12$370
Teva Pharmaceuticals USA, Inc.9$329
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)19$294
Braeburn Inc.7$208
Supernus Pharmaceuticals, Inc.6$129
Bayer Healthcare Pharmaceuticals Inc.1$118
VERTEX PHARMACEUTICALS INCORPORATED2$113
ABBVIE INC.5$87
Janssen Pharmaceuticals, Inc3$65
Neurocrine BioSciences, Inc.3$63

Products named: REXULTI, CAPLYTA, AUSTEDO XR, BRIXADI, Qelbree, Kerendia, VRAYLAR, SPRAVATO.

Industry payments across AL — which companies pay providers there.